capd 19 solution for peritoneal dialysis
fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g; glucose as monohydrate 25 g; calcium chloride 0.1838 g; sodium chloride 5.786 g; lactic acid as sodium 3.925 g - combinations - combinations - for use in patients with end-stage (decompensated )chronic renal failure of any origin which can be treated with peritoneal dealysis.17/10/2017 בקשה לשינוי משטר מינוןשינוי משטר מינון בהתאם למאושר באירופה
capd 2 peritoneal dialysis solution
fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 16.5 g/l; lactic acid as sodium 3.925 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.
capd 3 peritoneal dialysis solution
fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - lactic acid as sodium 3.925 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 46.75 g/l; magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.
capd 4 peritoneal dialysis solution
fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - calcium chloride 0.2573 g/l; sodium chloride 5.786 g/l; glucose as monohydrate 25 g/l; lactic acid as sodium 3.925 g/l; magnesium chloride 0.1017 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.
dianeal pd-4 peritoneal dialysis solution with 3.86 % glucose
baxter healthcare distribution ltd., israel - calcium chloride; glucose; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose 38.6 g/l; lactic acid as sodium 4.5 g/l; glucose as monohydrate 42.5 g/l; magnesium chloride 0.051 g/l; sodium chloride 5.4 g/l; calcium chloride 0.184 g/l - isotonic solutions - indicated whenever peritoneal dialysis is employed including acute and chronic renal failure, severe water retention, electrolyte disorders, drug intoxication.
dianeal pd-4 peritoneal dialysis solution with 2.27 % glucose
baxter healthcare distribution ltd., israel - calcium chloride; glucose; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - lactic acid as sodium 4.5 g/l; sodium chloride 5.4 g/l; glucose 22.7 g/l; calcium chloride 0.184 g/l; magnesium chloride 0.051 g/l; glucose as monohydrate 25 g/l - indicated whenever peritoneal dialysis is employed including acute and chronic renal failure, severe water retention, electrolyte disorders, drug intoxication.
dialysis chair
harsh pharmaceuticals limited, tanzania - haemodialysis chair base a3 grey/blue -
sabax dianeal ls 4,25 (peritoneal dialysis solution)
adcock ingram critical care (pty) ltd - combination peritoneal dialysis solution - dialysis solution - combination peritoneal dialysis solution
sabax normal calcium with 1,5% glucose (peritoneal dialysis)
adcock ingram critical care (pty) ltd - combination peritoneal dialysis solution - dialysis solution - combination peritoneal dialysis solution
dialysate, haemodialysis
baxter healthcare pty ltd - 35849 - dialysate, haemodialysis - diasol are used for the production of dialysate during hd therapy. dialysis treatment is to allow the removal by diffusion of excess uremic waste products, achive electrolyte haemostasis and to supply of buffer in order to restore normal ph levels.